Literature DB >> 942271

Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.

A A Eghtedari, P Davis, P A Bacon.   

Abstract

Circulating immunoblasts were studied in 39 cases of ankylosing spondylitis. The results were compared with 20 normal subjects and a group of 39 patients with rheumatoid arthritis, Immunoblasts were found to be increased in 11 patients with ankylosing spondylitis and in 22 patients with rheumatoid arthritis in contrast to the controls who were found to have a normal lymphoid cell population in the peripheral blood. Fifteen patients showed raised levels of one or more class of immunoglobulin. Autoantibodies, including antinuclear factors, were negative in all cases. There was a correlation between raised immunoblasts and plasma viscosity but not with clinical assessment of activity. The increase of immunoblasts in the peripheral blood, together with the raised immunoglobulins supports the suggestion of an immunological basis for ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942271      PMCID: PMC1006528          DOI: 10.1136/ard.35.2.155

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

2.  Character of anti-DNA antibodies in systemic lupus erythematosus.

Authors:  S A Cohen; G R Hughes; G L Noel; C L Christian
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

3.  Synovial fluid in ankylosing spondylitis.

Authors:  M J Kendall; M Farr; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

4.  Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes.

Authors:  G Torrigiani; I M Roitt
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

5.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

6.  Response of human blood lymphocytes to tuberculin PPD in tissue culture.

Authors:  A S Coulson; D G Chalmers
Journal:  Immunology       Date:  1967-04       Impact factor: 7.397

7.  Synovial inflammatory cell reaction in chronic arthritis.

Authors:  H Julkunen
Journal:  Acta Rheumatol Scand       Date:  1966

8.  Reactive lymphoid cells ('Immunoblasts') in autoimmune and haematological disorders.

Authors:  P A Bacon; R L Sewell; D Crowther
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

9.  Lymphoid cellular responses in the blood after immunization in man.

Authors:  D Crowther; G H Fairley; R L Sewell
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

  9 in total
  13 in total

1.  Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Authors:  Cynthia Wright; Sahar Sibani; David Trudgian; Roman Fischer; Benedikt Kessler; Joshua LaBaer; Paul Bowness
Journal:  Mol Cell Proteomics       Date:  2012-02       Impact factor: 5.911

2.  Polyclonal B cell activation in ankylosing spondylitis.

Authors:  P Barbieri; I Olivieri; G Benedettini; P Marelli; M L Ciompi; G Pasero; M Campa
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

3.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

4.  Circulating immunoblasts in polymyalgia rheumatica.

Authors:  A A Eghtedari; W Esselinckx; P A Bacon
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

5.  Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Authors:  J N Rosenberg; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

6.  Neutrophil chemotaxis in ankylosing spondylitis, Reiter's disease, and polymyalgia rheumatica.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  The absence of circulating immune complexes in patients with ankylosing spondylitis.

Authors:  W Maksymowych; M K Dasgupta; R S Rothwell; J B Dossetor; A S Russell
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

8.  Immunoregulatory T cells in the peripheral blood of patients with Bechterew's syndrome.

Authors:  O Vinje; J H Dobloug; O Førre; P Møller; O J Mellbye
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

9.  Subpopulations of T lymphocytes in patients with ankylosing spondylitis.

Authors:  E Nilsson; G Biberfeld
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

10.  Ankylosing spondylitis: an autoimmune disease?

Authors:  H J Lakomek; M Plomann; C Specker; M Schwochau
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.